New Veeva system combines CTMS and eTMF in the cloud

“The industry is struggling with legacy technology, disconnected applications, and process silos across clinical operations​,” Jennifer Goldsmith, Senior VP of Veeva Vault, Veeva Systems, told Outsourcing-Pharma.com.

In a recent survey of eTMF owners, 49% cited integration between their eTMF and CTMS applications as a key need. According to Goldsmith, Veeva Vault CTMS solves a big need in unifying clinical information, documentation, and processes globally.

“When you combine CTMS with eTMF and Study Startup, that’s a real-game changer for customers that have traditionally struggled to share information between these systems​,” she said.

“With the addition of CTMS, now we can provide them a unified clinical suite of applications​,” added Goldsmith, which she said is the “the first and only one​.”

Demand​

The demand for next-generation CTMS solutions is driven by a number of factors. Mainly, there is a lack of real-time visibility into trial or portfolio statuses.

“There is also a lack of confidence in the integrity of clinical operations master data because it lives in so many different systems and is often duplicated from one system to the next​,” added Goldsmith.

She also added that there is an inability to view and access clinical operations data from a single system, which makes collaboration between sponsors, CROs, and investigator sites difficult. “This all creates significant limitations in how clinical trials are planned and executed​,” Goldsmith said.

Vault CTMS is expected to be available in the first quarter of 2017.